CU Boulder experts provide an update on the status of the delta variant in the United States, takeaways from the latest data on vaccines and breakthrough COVID-19 cases, and how the campus is approaching its sustainable response to the pandemic.
CU Boulder researchers have discovered a potent, drug-like compound that could someday revolutionize treatment of autoimmune diseases by inhibiting a protein instrumental in prompting the body to start attacking its own tissue.
The University of Colorado Boulder has received a $1.1 million grant from the Bill & Melinda Gates Foundation to develop next-generation vaccines that require no refrigeration and defend against infectious diseases with just one shot.
Loren Hough has won a New Investigator Maximizing Investigators’ Research Award from the National Institutes of Health to further vital research in the field of biophysics, specifically the behavior of tubulin, a protein involved in many life processes.
Humans have used Saccharomyces cerevisiae yeast in baking, brewing and winemaking for millennia. New research from the University of Idaho and CU Boulder reveals another way that yeast species can help our species: by demonstrating how viruses interact with their hosts, and how hosts may evolve to fight back.
Joel Kralj, assistant professor in molecular, cellular and developmental biology and a University of Colorado BioFrontiers Institute faculty member, became interested in measuring cellular voltage as a postdoctoral researcher.